M Bell, J M Hunter, S M Mostafa. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » HumansImmune ToleranceInfluenza B virusInfluenza, Human/drug therapyMaleMiddle AgedNebulizers and VaporizersPneumonia, Viral/drug therapyRespiration, ArtificialRibavirin/administration & dosageRibavirin/therapeutic useRibonucleosides/administration & dosage
Substances: See more » RibonucleosidesRibavirin
Year: 1988 PMID: 2903314 DOI: 10.1016/s0140-6736(88)90109-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321